Biomedical Engineering Reference
In-Depth Information
283. Parak, W.; Gerion, D.; Pellegrino, T.; Zanchet, D.; Micheel, C.; Williams, S.; Boudreau, R.;
Le Gros, M.; Larabell, C.; Alivisatos, A. Biological Applications of Colloidal Nanocrystals.
Nanotechnology 2003, 14, R15-R27.
284. Niemeyer, C. Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Sci-
ence. Angew Chem. Int. Ed. 2001, 40, 4128-4158.
285. Barbosa, S.; Agrawal, A.; Rodríguez-Lorenzo, L.; Pastoriza-Santos, I.; Alvarez-Puebla, R. A.;
Kornowski, A.; Weller, H.; Liz-Marzan, L. M. Tuning Size and Sensing Properties in Colloidal
Gold Nanostars. Langmuir 2010, 26, 14943-14950.
286. Hu, J.; Li, L.; Yang, W.; Manna, L.; Wang, L.; Alivisatos, A. P. Linearly Polarized Emission
from Colloidal Semiconductor Quantum Rods. Science 2001, 292, 2060-2063.
287. Grieshaber, D.; MacKenzie, R.; Voros, J.; Reimhult, E. Electrochemical Biosensors-Sensor
Principles and Architectures. Sensors 2008, 8, 1400-1458.
288. Tothill, I. T. Review: Biosensors for Cancer Markers Dignostics. Semin. Cell Dev. Biol. 2009,
20, 55-62.
289. Aspden, T. J.; Mason, J. D.; Jones, N. S. Chitosan as a Nasal Delivery System: The Effect of
Chitosan Solutions on In Vitro and In Vivo Mucociliary Transport Rates in Human Turbinates
and Volunteers. J. Pharm. Sci. 1997, 86, 509-513.
290. Blum, J. L.; Savin, M. A.; Edelman, G.; Pippen, J. E.; Robert, N. J.; geister, B. V.; Kirby, R.
L.; Clawson, A.; O'shaughnessy, J. A. Phase II Study of Weekly Albumin-bound Paclitaxel for
Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes. Clin. Breast. Cancer
2007, 7, 850-856.
291. El-Sayed, I. H. Nanotechnology in Head and Neck Cancer: The Race is on. Curr. Oncol. Rep.
2010, 12, 121-128.
292. Ge, H.; Hu, Y.; Jiang, X.; Cheng, D.; Yuan, Y.; Bi, H.; Yang, C. Preparation, Characteriza-
tion, and Drug Release Behaviors of Drug Nimodipine-Loaded Poly(epsilon-caprolactone)-
Poly(ethylene oxide)-Poly(epsilon-caprolactone) Amphiphilic Triblock Copolymer Micelles.
J. Pharm. Sci. 2002, 91, 1463-1473.
293. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The Drawbacks and
Advantages of Vehicle Selection for Drug Formulation. Eur. J. Cancer 2001, 37, 1590-1598.
294. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M. C.; Stolnik, S.; Illum, L.; Davis, S. S. Defining
the Drug Incorporation Properties of PLA-PEG Nanoparticles. Int. J. Pharm. 2000, 199, 95-110.
295. Gradishar, W. J.; Tjulandin, S.; Davidson, N.; Shaw, H.; Desai, N.; Bhar, P.; Hawkins, M.;
O'Shaughnessy, J. Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared with
Polyethylated Castor Oil-Based Paclitaxel in Women with Breast Cancer. J. Clin. Oncol.
2005, 23, 7794-7803.
296. Hans, M. L.; Lowman, A. M. Biodegradable Nanoparticles for Drug Delivery and Targeting.
Curr. Opin. Solid State Mater. Sci. 2002, 6, 319-327.
297. La, S. B.; Okano, T.; Kataoka, K. Preparation and Characterization of Micelle-Forming Poly-
meric Drug Indomethacin-Incorporated Poly(Ethylene oxide)-Poly(β-benzyl l-aspartate)
Block Copolymer Micelles. J. Pharm. Sci. 1996, 85, 85-90.
298. Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schäfer, U.; Takeuchi, H.; Maincent, P.;
Kawashima, Y.; Lehr, C. M. Biodegradable Nanoparticles for Targeted Drug Delivery in Treat-
ment of Inflammatory Bowel Disease. J Pharmacol. Exp. Ther. 2001, 299, 775-781.
299. Mamot, C.; Drummond, D. C.; Hong, K.; Kirpotin, D. B.; Park, J. W. Liposome-based
Approaches to Overcome Anticancer Drug Resistance. Drug Resist. Updat. 2003, 6, 271-279.
300. Miller, D. W.; Batrakova, E. V.; Kabanov, A. V. Inhibition of Multidrug Resistance-Associated
Protein (MRP) Functional Activity with Pluronic Block Copolymers. Pharm. Res. 1999, 16,
396-401.
Search WWH ::




Custom Search